Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?

被引:1
|
作者
Hohenberger, Peter [1 ]
机构
[1] Heidelberg Univ, Fac Med, Dept Surg, Div Surg Oncol & Thorac Surg, D-68167 Mannheim, Germany
来源
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 05期
关键词
D O I
10.1038/ncponc1091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:240 / 241
页数:2
相关论文
共 50 条
  • [11] Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib.
    Cormier J.N.
    Patel S.R.
    Pisters P.W.
    Current Oncology Reports, 2002, 4 (6) : 504 - 509
  • [12] Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors
    Centonze, D.
    Pulvirenti, E.
    D'Urso, A. Pulvirenti
    Franco, S.
    Cinardi, N.
    Giannone, G.
    TECHNIQUES IN COLOPROCTOLOGY, 2013, 17 (05) : 571 - 574
  • [13] Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors
    Lai, IR
    Hu, RH
    Chang, KJ
    HEPATO-GASTROENTEROLOGY, 2005, 52 (63) : 826 - 828
  • [14] Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors
    D. Centonze
    E. Pulvirenti
    A. Pulvirenti D’Urso
    S. Franco
    N. Cinardi
    G. Giannone
    Techniques in Coloproctology, 2013, 17 : 571 - 574
  • [15] Approval Summary: Imatinib Mesylate for One or Three Years in the Adjuvant Treatment of Gastrointestinal Stromal Tumors
    Cohen, Martin H.
    Johnson, John R.
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2012, 17 (07): : 992 - 997
  • [16] Update on imatinib for gastrointestinal stromal tumors: duration of treatment
    Linch, Mark
    Claus, Jeroen
    Benson, Charlotte
    ONCOTARGETS AND THERAPY, 2013, 6 : 1011 - 1023
  • [17] Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor
    Ling, Jiayu
    Shi, Lishuo
    Cheng, Xingyu
    Fu, Yang
    Lin, Ziqin
    Zhao, Yandong
    Li, Zheqing
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Deng, Yanhong
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 73 - 84
  • [18] Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors
    Eisenberg, Burton L.
    Trent, Jonathan C.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (11) : 2533 - 2542
  • [19] Follow up of three cases after adjuvant treatment of high risk gastrointestinal stromal tumors with Imatinib
    Armbrust, T.
    Sobotta, M.
    Ramadori, G.
    ANNALS OF ONCOLOGY, 2007, 18 (06) : 1123 - 1125
  • [20] Efficacy evaluation of imatinib in the treatment of patients with gastrointestinal stromal tumors
    Zong, Liang
    Chen, Ping
    Zhao, Wei
    Shi, Lei
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2011, 22 (05): : 479 - 485